SA-6817

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameSA-6817
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitorsEndopeptidases inhibitors
TargetsAngiotensin-converting enzymeEndopeptidases
Therapy Area/IndicationsHypertensionHeart FailureRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanten Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanten Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHypertensionHeart FailureRenal Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A